# Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5

Article · Robert F. Kushner, Salvatore Calanna, Melanie Jane Davies, Dror Dicker, William Timothy Garvey, Bryan Goldman, Ildiko Lingvay, Mette Thomsen, Thomas A. Wadden, Sean Wharton, John P.H. Wilding, Domenica Rubino

- Archive id: doi:10.1002/oby.22794
- Published: 2020-05-22
- Venue: Obesity
- DOI: https://doi.org/10.1002/oby.22794
- PMID: 32441473
- Citations: 288
- Source URL: https://doi.org/10.1002/oby.22794
- PDF: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/oby.22794
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.